Time for US companies to get to know the UPC

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Time for US companies to get to know the UPC

Managing IP is holding events in San Jose and New York in December to bring US companies up to date with everything they need to know about the Unified Patent Court and how it will affect them, with in-house counsel being offered complementary attendance

european-usa-forum.jpg

With the UPC completely reshaping the litigation landscape in Europe, now is the time for strategies to be put into place to prepare for this change. This is something that is uppermost in European companies’ priorities at the moment.

But are US companies falling behind in this regard?

They already have enough on their plates, with the fallout from recent Supreme Court decisions working their way through the courts and the USPTO, debates on patent trolls, and potential new legislation in Congress. As a result, US companies may not be focusing enough attention on the reform in Europe, giving away a strong competitive advantage to its European competitors.

A good place to start is with our handy overview of the biggest questions around the UPC and the Unitary Patent here and our guide to UPC resources here.

However, to really bring US corporations up to speed, Managing IP is holding the European Patent Reform Forum USA in San Jose on December 10 and New York on December 12. Registration is still open at www.managingip.com/eupatentusa

Join us to learn all you need to know about the UPC, get direct insights from the preparatory committee, hear from the EPO and listen to expert advice for US corporations to prepare for the reform.

As usual, attendance is free for in-house counsel, IP managers and R&D professionals. You can register at www.managingip.com/eupatentusa or simply email your details to register@managingip.com

The expert panels include leading European IP experts, a member of the drafting committee as well as well renowned US in-house counsel:

• Stefan Luninbuehl, international legal affairs, European Patent Office

• Pierre Véron, partner, Véron & Associés and member of the drafting committee

• Michael Schneider, partner, Wragge Lawrence Graham & Co

• Larry Horn, CEO, MPEG LA

• Catherine Lacavera, director of litigation, Google

• Pamela Simonton, executive vice president and general counsel, Exelixis Pharmaceuticals

• Sherry Knowles, principal, Knowles Intellectual Property Strategies

• Katy Motiey, Chief Legal Officer, Spansion

• Nicola Dagg, partner, Allen & Overy

• Michael Moore, deputy general counsel, Rambus

• Kim Jessum, associate general counsel, Heraeus Incorporated

• Roger Kuan, senior IP counsel, Thermo Fisher Scientific

• And many more

Register for free at: www.managingip.com/eupatentusa

or simply email your details to register@managingip.com

more from across site and SHARED ros bottom lb

More from across our site

AG Barr acquires drinks makers Fentimans and Frobishers, in deals worth more than £50m in total
Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Gift this article